Catalyst Wire Dossier Catalyst Wire Dossier

EscharEx (EX-02 Formulation)

EscharEx EX-02 · MediWound Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EscharEx (EX-02 Formulation), covering 2022-11-14 to 2022-11-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg Ulcers [Phase 2]

See pricing